Cargando…
Anti-CD47 Antibody Enhances the Efficacy of Chemotherapy in Patients with Gastric Cancer Liver Metastasis
Patients with gastric cancer liver metastasis (GCLM) are often treated with palliative care, and they show a poor prognosis. In gastric cancer, high CD47 expression has been shown to indicate a poor prognosis. CD47, expressed on the cell surface, prevents the cells from being phagocytosed by macroph...
Autores principales: | Liu, Zhaorui, Chen, Huiying, Ta, Na, Shi, Zheng, Zhan, Lu, Han, Ting, Zhang, Jinghui, Chang, Xusheng, Yin, Kai, Nie, Mingming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969583/ https://www.ncbi.nlm.nih.gov/pubmed/36860925 http://dx.doi.org/10.7150/jca.80725 |
Ejemplares similares
-
Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer
por: Jin, Xin, et al.
Publicado: (2022) -
CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016) -
Significance of CD47 expression in gastric cancer
por: Sudo, Tomoya, et al.
Publicado: (2017) -
Anti-CD47 antibody eliminates bone tumors in rats
por: Fang, Shiqiang, et al.
Publicado: (2019) -
Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer
por: Zhang, Jinghui, et al.
Publicado: (2021)